Cargando…
PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430058/ http://dx.doi.org/10.1097/01.HS9.0000974776.07083.ab |
_version_ | 1785090862888255488 |
---|---|
author | Fattizzo, Bruno Vercellati, Cristina Marcello, Anna Patel, Parija Wind-Rotolo, Megan Pettine, Loredana Leoni, Simona Fermo, Elisa Bianchi, Paola Zaninoni, Anna Barcellini, Wilma |
author_facet | Fattizzo, Bruno Vercellati, Cristina Marcello, Anna Patel, Parija Wind-Rotolo, Megan Pettine, Loredana Leoni, Simona Fermo, Elisa Bianchi, Paola Zaninoni, Anna Barcellini, Wilma |
author_sort | Fattizzo, Bruno |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430058 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104300582023-08-17 PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY Fattizzo, Bruno Vercellati, Cristina Marcello, Anna Patel, Parija Wind-Rotolo, Megan Pettine, Loredana Leoni, Simona Fermo, Elisa Bianchi, Paola Zaninoni, Anna Barcellini, Wilma Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430058/ http://dx.doi.org/10.1097/01.HS9.0000974776.07083.ab Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Fattizzo, Bruno Vercellati, Cristina Marcello, Anna Patel, Parija Wind-Rotolo, Megan Pettine, Loredana Leoni, Simona Fermo, Elisa Bianchi, Paola Zaninoni, Anna Barcellini, Wilma PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY |
title | PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY |
title_full | PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY |
title_fullStr | PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY |
title_full_unstemmed | PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY |
title_short | PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY |
title_sort | pb1990: glycolytic activity and effect of ex-vivo treatment with the pyruvate kinase (pk) activator ag-946 in red blood cells from low-risk myelodysplastic syndromes patients: a proof-of-concept study |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430058/ http://dx.doi.org/10.1097/01.HS9.0000974776.07083.ab |
work_keys_str_mv | AT fattizzobruno pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy AT vercellaticristina pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy AT marcelloanna pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy AT patelparija pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy AT windrotolomegan pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy AT pettineloredana pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy AT leonisimona pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy AT fermoelisa pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy AT bianchipaola pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy AT zaninonianna pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy AT barcelliniwilma pb1990glycolyticactivityandeffectofexvivotreatmentwiththepyruvatekinasepkactivatorag946inredbloodcellsfromlowriskmyelodysplasticsyndromespatientsaproofofconceptstudy |